Literature DB >> 33030307

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop.

Berislav V Zlokovic1, Rebecca F Gottesman2, Kenneth E Bernstein3, Sudha Seshadri4, Ann McKee5, Heather Snyder6, Steven M Greenberg7, Kristine Yaffe8, Chris B Schaffer9, Chun Yuan10, Timothy M Hughes11, Mat J Daemen12, Jeff D Williamson11, Hector M González13, Julie Schneider14, Cheryl L Wellington15, Zvonimir S Katusic16, Luke Stoeckel17, James I Koenig18, Roderick A Corriveau18, Lawrence Fine19, Zorina S Galis19, Jared Reis19, Jacqueline D Wright19, Jue Chen19.   

Abstract

Vascular contributions to cognitive impairment and dementia (VCID) are characterized by the aging neurovascular unit being confronted with and failing to cope with biological insults due to systemic and cerebral vascular disease, proteinopathy including Alzheimer's biology, metabolic disease, or immune response, resulting in cognitive decline. This report summarizes the discussion and recommendations from a working group convened by the National Heart, Lung, and Blood Institute and the National Institute of Neurological Disorders and Stroke to evaluate the state of the field in VCID research, identify research priorities, and foster collaborations. As discussed in this report, advances in understanding the biological mechanisms of VCID across the wide spectrum of pathologies, chronic systemic comorbidities, and other risk factors may lead to potential prevention and new treatment strategies to decrease the burden of dementia. Better understanding of the social determinants of health that affect risks for both vascular disease and VCID could provide insight into strategies to reduce racial and ethnic disparities in VCID.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease-related dementias; cerebrovascular and cardiovascular disease; vascular contributions to cognitive impairment and dementia

Year:  2020        PMID: 33030307     DOI: 10.1002/alz.12157

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  32 in total

1.  IGF1R signaling regulates astrocyte-mediated neurovascular coupling in mice: implications for brain aging.

Authors:  Stefano Tarantini; Priya Balasubramanian; Andriy Yabluchanskiy; Nicole M Ashpole; Sreemathi Logan; Tamas Kiss; Anna Ungvari; Ádám Nyúl-Tóth; Michal L Schwartzman; Zoltan Benyo; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2021-03-06       Impact factor: 7.713

2.  Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.

Authors:  Jennifer S Rabin; Jeremy Pruzin; Matthew Scott; Hyun-Sik Yang; Olivia Hampton; Stephanie Hsieh; Aaron P Schultz; Rachel F Buckley; Trey Hedden; Dorene Rentz; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurology       Date:  2022-04-26       Impact factor: 11.800

3.  Association of cerebral microvascular dysfunction and white matter injury in Alzheimer's disease.

Authors:  Zsolt Bagi; Christopher D Kroenke; Katie Anne Fopiano; Yanna Tian; Jessica A Filosa; Larry S Sherman; Eric B Larson; C Dirk Keene; Kiera Degener O'Brien; Philip A Adeniyi; Stephen A Back
Journal:  Geroscience       Date:  2022-05-25       Impact factor: 7.581

Review 4.  Blood-Brain Barrier Dysfunction and the Potential Mechanisms in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment.

Authors:  WenQing Xu; Qingke Bai; Qiang Dong; Min Guo; Mei Cui
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

5.  One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study.

Authors:  Yu-Hui Liu; Yang Chen; Qing-Hua Wang; Ling-Ru Wang; Li Jiang; Ying Yang; Xian Chen; Ying Li; Yuan Cen; Cheng Xu; Jie Zhu; Wei Li; Ye-Ran Wang; Li-Li Zhang; Juan Liu; Zhi-Qiang Xu; Yan-Jiang Wang
Journal:  JAMA Neurol       Date:  2022-05-01       Impact factor: 29.907

6.  Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling.

Authors:  Charles E Seaks; Erica M Weekman; Tiffany L Sudduth; Kevin Xie; Brandi Wasek; David W Fardo; Lance A Johnson; Teodoro Bottiglieri; Donna M Wilcock
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-13       Impact factor: 6.960

7.  Relationship between Retinal Vascular Occlusions and Cognitive Dementia in a Large Cross-Sectional Cohort.

Authors:  Alison X Chan; Christine Y Bakhoum; Katherine J Bangen; Mathieu F Bakhoum
Journal:  Am J Ophthalmol       Date:  2021-01-30       Impact factor: 5.488

8.  Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study.

Authors:  Huamin Liu; Lianwu Zou; Rui Zhou; Minyi Zhang; Shanyuan Gu; Jiazhen Zheng; Daniel Nyarko Hukportie; Keyi Wu; Zhiwei Huang; Zelin Yuan; Xianbo Wu
Journal:  Front Aging Neurosci       Date:  2021-06-17       Impact factor: 5.750

9.  Cognitive function among older adults with diabetes and prediabetes, NHANES 2011-2014.

Authors:  Sarah S Casagrande; Christine Lee; Luke E Stoeckel; Andy Menke; Catherine C Cowie
Journal:  Diabetes Res Clin Pract       Date:  2021-07-03       Impact factor: 8.180

10.  Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia.

Authors:  Katherine J Bangen; Denis S Smirnov; Lisa Delano-Wood; Christina E Wierenga; Mark W Bondi; David P Salmon; Douglas Galasko
Journal:  Alzheimers Res Ther       Date:  2021-07-01       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.